Kymera Therapeutics (KYMR) PT Raised to $155 at B.Riley

June 29, 2026 8:30 AM

B.Riley analyst Kalpit Patel raised the price target on Kymera Therapeutics (NASDAQ: KYMR) to $155.00 (from $117.00) while maintaining a Buy rating.

No results found